(Q74634432)
Statements
Omission of day +11 methotrexate after allogeneic bone marrow transplantation is associated with increased risk of severe acute graft-versus-host disease (English)
Litzow MR
Gertz MA
Lacy MQ
Kumar S
Wolf RC
Chen MG
Gastineau DA